GEHC

GE HealthCare Technologies
D

GEHC

Arincen60/100B
82.385
USD
-1.36
(-1.62%)
Post Trading·82.380USD-0.005(-0.01%)
Fair value76.47Plus+8%51Price 82.39119
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
OverviewFinancialsForecastEarningsDividendsCompany

GE HealthCare Technologies cash on hand 2020–2026

GE HealthCare Technologies had 2.85B USD in cash and short-term investments on 30 September 2026, down 28.7% on a year before. At the end of fiscal year 2025 it had 4.51B USD.

Last updated 7 Nov 2026 · Next report 3 Feb 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter30 Sept 20262.85B-28.74%10.41B-7.55B
FY202531 Dec 20254.51B+56.12%10.00B-5.49B
FY202431 Dec 20242.89B+15.42%9.38B-6.49B
FY202331 Dec 20232.50B+73.29%9.86B-7.36B
FY202231 Dec 20221.45B+159.89%8.64B-7.19B
FY202131 Dec 2021556.00M-44.79%437.00M119.00M
FY202031 Dec 20201.01B—468.00M539.00M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Balance sheet

Common questions about GE HealthCare Technologies's cash

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.